ITTO20020672A0 - Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale - Google Patents

Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale

Info

Publication number
ITTO20020672A0
ITTO20020672A0 IT2002TO000672A ITTO20020672A ITTO20020672A0 IT TO20020672 A0 ITTO20020672 A0 IT TO20020672A0 IT 2002TO000672 A IT2002TO000672 A IT 2002TO000672A IT TO20020672 A ITTO20020672 A IT TO20020672A IT TO20020672 A0 ITTO20020672 A0 IT TO20020672A0
Authority
IT
Italy
Prior art keywords
acids
pharmaceutical compositions
compositions containing
containing keto
endoperitoneal
Prior art date
Application number
IT2002TO000672A
Other languages
English (en)
Inventor
Jose Sebastian Franzone
Claudio Omini
Giuseppe Zuccari
Original Assignee
Medestea Res And Production S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medestea Res And Production S filed Critical Medestea Res And Production S
Priority to IT2002TO000672A priority Critical patent/ITTO20020672A1/it
Publication of ITTO20020672A0 publication Critical patent/ITTO20020672A0/it
Priority to AU2003251643A priority patent/AU2003251643A1/en
Priority to EP03766301A priority patent/EP1545456A1/en
Priority to US10/522,154 priority patent/US20050239888A1/en
Priority to PCT/EP2003/008226 priority patent/WO2004012706A1/en
Publication of ITTO20020672A1 publication Critical patent/ITTO20020672A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT2002TO000672A 2002-07-26 2002-07-26 Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale ITTO20020672A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT2002TO000672A ITTO20020672A1 (it) 2002-07-26 2002-07-26 Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
AU2003251643A AU2003251643A1 (en) 2002-07-26 2003-07-25 Pharmaceutical compositions containing keto-acids for endoperitoneal administration
EP03766301A EP1545456A1 (en) 2002-07-26 2003-07-25 Pharmaceutical compositions containing keto-acids for endoperitoneal administration
US10/522,154 US20050239888A1 (en) 2002-07-26 2003-07-25 Pharmaceutical compositions containing keto-acids for endoperitoneal administration
PCT/EP2003/008226 WO2004012706A1 (en) 2002-07-26 2003-07-25 Pharmaceutical compositions containing keto-acids for endoperitoneal administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002TO000672A ITTO20020672A1 (it) 2002-07-26 2002-07-26 Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale

Publications (2)

Publication Number Publication Date
ITTO20020672A0 true ITTO20020672A0 (it) 2002-07-26
ITTO20020672A1 ITTO20020672A1 (it) 2004-01-26

Family

ID=11459542

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002TO000672A ITTO20020672A1 (it) 2002-07-26 2002-07-26 Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale

Country Status (5)

Country Link
US (1) US20050239888A1 (it)
EP (1) EP1545456A1 (it)
AU (1) AU2003251643A1 (it)
IT (1) ITTO20020672A1 (it)
WO (1) WO2004012706A1 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880345A1 (fr) * 2004-12-30 2006-07-07 Adisseo Ireland Ltd Synthese et applications de l'acide 2-oxo-4-methylthiobutyrique, ses tels et ses derives
EP1948151A4 (en) * 2005-11-18 2009-12-02 Renobiz Co Ltd COMPOSITIONS USED FOR PERITONEAL DIALYSIS
IT1397446B1 (it) 2010-01-12 2013-01-10 Professional Dietetics Srl Compositions comprising amino acids for prevention and/or treatment of renal disorders.
CN104316641B (zh) * 2014-10-20 2015-11-18 华东理工大学 酮苯丙氨酸钙中杂质含量的检测方法
ES2882278T3 (es) 2018-07-31 2021-12-01 Evonik Operations Gmbh Mezclas de cetoácidos de cadena ramificada (BCKA) y procedimiento para la producción de tales mezclas
CA3119220A1 (en) * 2018-11-12 2020-05-22 Evonik Operations Gmbh Culture medium comprising keto acids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511302A (en) * 1974-04-15 1978-05-17 Univ Johns Hopkins Pharmaceutical compositions comprising amino acid analogues
ATE82500T1 (de) * 1984-06-22 1992-12-15 Richard L Veech Elektrolytloesungen und deren (in vivo) verwendung.
US4752619A (en) * 1985-12-23 1988-06-21 The Johns Hopkins University Nutritional supplement for treatment of uremia
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
KR100309972B1 (ko) * 1992-12-22 2001-12-28 데이비드 씨. 맥키, 토마스 제어. 시바티노 복막투석환자치료용의개량아미노산용액
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
AU701724B2 (en) * 1994-07-01 1999-02-04 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions

Also Published As

Publication number Publication date
AU2003251643A1 (en) 2004-02-23
EP1545456A1 (en) 2005-06-29
WO2004012706A1 (en) 2004-02-12
ITTO20020672A1 (it) 2004-01-26
US20050239888A1 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
GB2389530B (en) Pharmaceutical compositions
PT1501534E (pt) Formulacoes farmaceuticas
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
EP1551402A4 (en) PHARMACEUTICAL COMPOSITIONS NOT INDUCING ABUSE
IL159725A0 (en) Pharmaceutical compositions containing benzimidazole derivatives
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20001749A0 (fi) Farmaseuttisia koostumuksia
PT1242087E (pt) Composicoes farmaceuticas
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DK1587478T3 (da) Farmaceutisk sammensætning
GB2391473B (en) Pharmaceutical compositions
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
IS7051A (is) Lyfjasamsetningar
IS7458A (is) Stöðug lyfjablanda sem inniheldur þátt VIII
NO20041383L (no) Flashsmelte oral doseringsformulering
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
PT1239832E (pt) Composicoes farmaceuticas
GB0213481D0 (en) Pharmaceutical compositions
ITTO20020672A1 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
NO20043633L (no) Oral doseringsform for kontrollert medikamentfrigivning
EP1480649A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NO20044164L (no) Farmasoytiske sammensetninger
EE200200689A (et) Ravimkoostised